Home » Topics » BioWorld Science

BioWorld Science
RSS

GSK initiates phase II study of SARM GSK-2881078 in patients with COPD

April 3, 2018

NIAID initiates phase I study of HIV-1 vaccines

April 3, 2018

FN-1501 identified as a novel FLT-3 and CDK inhibitor for the treatment of AML

April 3, 2018

C4X licenses orexin-1 receptor antagonist C4X-3256 to Indivior

March 29, 2018

Redx suspends enrollment in phase I/IIa study of RXC-004

March 29, 2018

Zeria Pharmaceutical applies for approval of Z-213 in Japan

March 29, 2018

Takeda considers making offer for Shire

March 29, 2018

Janssen files for approval of apalutamide in Japan

March 29, 2018

Prometic Life Sciences offers new data from phase II study of PBI-4050 in Alstrom syndrome

March 29, 2018

METTL3 linked to hepatocellular carcinogenesis

March 29, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Cosmo data positive for first new hair-loss approach in decades
BioWorld
Shares of Cosmo Pharmaceuticals NV rose sharply on Dec. 3 following top-line pivotal phase III data showing a statistically significant and clinically meaningful...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...